“I Was Very Impressed” by Medline (MDLN)’s IPO, Says Jim Cramer

We recently published 10 Stocks Jim Cramer Talked About.  Medline Inc. (NASDAQ:MDLN) is one of the stocks Jim Cramer discussed recently.

Medical supplies and instrument firm Medline Inc. (NASDAQ:MDLN)’s shares underwent their public listing earlier this month. The firm raised $6.26 billion in the offering. Medline Inc. (NASDAQ:MDLN)’s IPO is among the few this year that has been backed heavily by players in the private equity market, with Blackstone, Carlyle, and Hellman all having held a stake in the pre-IPO entity after buying it in 2021. The IPO’s multi-billion-dollar capital raise also made it the largest IPO of 2025, which was striking given that Medline Inc. (NASDAQ:MDLN) is not exposed to or engaged in the AI industry. Cramer discussed the IPO on his Mad Money appearance and commented that the stock looked a “little too expensive” to him. In this appearance, he shared that he was impressed by the listing and praised the firm:

“I was very impressed by it. I did a piece last night, saying, it’s a little too high for me now, but, uh, it’s the kind of deal that I like to see. People making money on both sides. I think it probably comes in a little and then you can buy it. . .it’s a very good company. . .David this was the best one to start the process. Very good growth, accelerating growth.

“I like this company and I think that if you get it, 32, it would be good. And it can come down, we know that the IPOs with shares that have started too high and they come down.”

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.